Prostate Cancer Clinical Trials
Prostate Cancer clinical trials evaluate new drugs, immunotherapies, radiation approaches, and combination treatments for prostate Cancer. Corterve aggregates actively recruiting Prostate Cancer studies from the public ClinicalTrials.gov registry so you can browse them by location and eligibility. Many oncology trials enroll patients at different stages of disease, including newly diagnosed and previously treated. This is general information, not medical advice — review any study with your oncology care team before enrolling.
Recruiting Prostate Cancer studies
- Imaging Studies to Check the Local Response of Prostate Cancer to Radiation TherapyNCT01834001National Cancer Institute (NCI)Bethesda, Maryland
- A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular LymphomaNCT03460977PHASE1PfizerTucson, Arizona
- A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.NCT06629779PHASE3PfizerChandler, Arizona
- Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate CancerNCT04812366PHASE2University of British ColumbiaSacramento, California
- RecoverPC: Relugolix vs GnRH Agonist in Quality of LifeNCT05765500PHASE2Dana-Farber Cancer InstituteBoston, Massachusetts
- Evaluation of Neoadjuvant Xaluritamig in Localized Prostate CancerNCT06613100PHASE1AmgenSan Francisco, California
- A Study on the Effects of Exercise Therapy on Signs of Prostate CancerNCT05751434PHASE2City of Hope Medical CenterDurate, California
- Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic AnalysisNCT01441089National Cancer Institute (NCI)Bethesda, Maryland
- A Study to Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Adult Male Participants With Metastatic Prostate CancerNCT07192614PHASE1, PHASE2AstraZenecaOrlando, Florida
- Exercise to Enhance Cardiovascular Health Among Black Prostate Cancer Patients With Androgen Deprivation TherapyNCT05327465NADana-Farber Cancer InstituteBoston, Massachusetts
- Clinical Outcomes in Prostate Cancer Patients Undergoing HIFU AblationNCT07203482NYU Langone HealthBrooklyn, New York
- Collection of Blood From Patients With Prostate CancerNCT00923221National Cancer Institute (NCI)Bethesda, Maryland
Prostate Cancer trials by state
Prostate Cancer trials by metro
Frequently asked questions
- How do I find recruiting Prostate Cancer clinical trials?
- Corterve aggregates actively recruiting Prostate Cancer studies from the public ClinicalTrials.gov registry. Browse the studies listed on this page or take a free health assessment to see trials you may qualify for based on your profile.
- Are Prostate Cancer clinical trials free to join?
- Study participation is typically free — research sponsors cover the cost of the investigational treatment and study-related visits. Many trials also compensate participants for time and travel. Details vary by study.
- Who can take part in a Prostate Cancer clinical trial?
- Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.